Share Article

Independent review confirms accurate analysis by Urenco

16 February 2016 Local News

At the request of the Dutch authority for nuclear safety and radiation protection (ANVS), the independent research institute RIVM, conducted a review of the radiological measurements and analysis reported by Urenco after the incident which took place in separation plant SP5 in August 2015. The review concluded that “sampling and analysis were conducted correctly by Urenco.”

Share Article

Line

More local stories

Cooperation between vocational schools and nuclear sector to develop Dutch nuclear curriculum

Local 12 January 2024

Jointly enhance the influx of employees needed for nuclear ambitions

Read more

Jointly enhance the influx of employees needed for nuclear ambitions

Read more

Sharing expertise at the Waste Management Symposium

Local 15 March 2022

Colleagues from Urenco Nuclear Stewardship joined industry professionals at the Waste Management Symposium in Phoenix, Arizona.

Read more

Colleagues from Urenco Nuclear Stewardship joined industry professionals at the Waste Management Symposium in Phoenix, Arizona.

Read more

About Urenco

Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.

With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.

We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.